DMK PHARMACEUTICALS Corp Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
DMK PHARMACEUTICALS Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2023.
  • DMK PHARMACEUTICALS Corp Operating Income (Loss) for the quarter ending September 30, 2023 was -$3.27M, a 29.4% increase year-over-year.
  • DMK PHARMACEUTICALS Corp Operating Income (Loss) for the twelve months ending September 30, 2023 was -$25.3M, a 11.7% increase year-over-year.
  • DMK PHARMACEUTICALS Corp annual Operating Income (Loss) for 2022 was -$25.1M, a 21.9% increase from 2021.
  • DMK PHARMACEUTICALS Corp annual Operating Income (Loss) for 2021 was -$32.1M, a 11.8% increase from 2020.
  • DMK PHARMACEUTICALS Corp annual Operating Income (Loss) for 2020 was -$36.3M, a 23.8% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$25.3M -$3.27M +$1.36M +29.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$26.7M -$11.3M -$3.13M -38.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 -$23.6M -$6.43M +$1.49M +18.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$25.1M -$4.34M +$3.64M +45.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 -$28.7M -$4.63M +$5.59M +54.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$34.3M -$8.18M -$524K -6.85% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$33.8M -$7.91M -$1.69M -27.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$32.1M -$7.98M +$1.36M +14.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$33.4M -$10.2M -$4.72M -85.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$28.7M -$7.65M +$3.59M +32% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$32.3M -$6.22M +$4.04M +39.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$36.3M -$9.34M -$3.68M -65% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$32.7M -$5.5M +$1.51M +21.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$34.2M -$11.2M -$3.5M -45.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-22
Q1 2020 -$30.7M -$10.3M -$1.32M -14.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-22
Q4 2019 -$29.4M -$5.66M +$7.62M +57.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$37M -$7.01M +$1.9M +21.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$38.9M -$7.75M +$1.93M +19.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-17
Q1 2019 -$40.8M -$8.94M -$1.33M -17.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 -$39.5M -$13.3M -$4.91M -58.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$34.6M -$8.91M -$3.11M -53.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$31.4M -$9.67M -$4.76M -96.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$26.7M -$7.61M -$1.9M -33.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$24.8M -$8.37M -$3.19M -61.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$21.6M -$5.8M +$779K +11.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$22.4M -$4.92M +$2.51M +33.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$24.9M -$5.71M +$308K +5.12% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$25.2M -$5.18M -$2.32M -81% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$22.9M -$6.58M -$3.27M -98.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$19.6M -$7.43M -$3.9M -110% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$15.7M -$6.02M -$1.87M -45% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$13.9M -$2.86M +$447K +13.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$14.3M -$3.31M -$1.37M -70.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$12.9M -$3.53M -$781K -28.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$12.2M -$4.15M -$2.43M -142% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$9.72M -$3.31M -$2.33M -236% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$7.39M -$1.94M -$984K -103% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$6.41M -$2.75M -$2.01M -272% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$4.4M -$1.71M -$820K -91.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$3.58M -$984K -$237K -31.6% Oct 1, 2013 Dec 31, 2013 10-Q 2014-02-14
Q3 2013 -$3.34M -$957K -$106K -12.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$3.23M -$740K -$15K -2.08% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$3.22M -$894K +$239K +21.1% Jan 1, 2013 Mar 31, 2013 10-K 2014-06-23
Q4 2012 -$3.46M -$748K +$241K +24.4% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$3.7M -$851K +$629K +42.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$4.33M -$725K +$488K +40.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-19
Q1 2012 -$4.82M -$1.13M -$15K -1.34% Jan 1, 2012 Mar 31, 2012 10-K 2013-07-03
Q4 2011 -$4.8M -$989K +$2.03M +67.3% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 -$6.83M -$1.48M -$368K -33.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$6.46M -$1.21M -$224K -22.6% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-17
Q1 2011 -$6.24M -$1.12M Jan 1, 2011 Mar 31, 2011 10-K 2012-06-29
Q4 2010 -$3.02M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$1.11M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$989K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.